Zivo Bioscience, Inc.
ZIVO
$12.00
-$4.00-25.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 16.09% | -24.31% | -297.78% | 35.20% | 27.73% |
| Total Depreciation and Amortization | 8.02% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5,339.84% | 1,372.78% | 12,917.26% | -1.44% | -98.83% |
| Change in Net Operating Assets | -106.61% | 120.70% | -95.94% | -89.24% | 684.24% |
| Cash from Operations | -26.55% | 44.91% | 36.73% | 20.19% | 50.54% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -- | -100.00% | -14.53% | -- |
| Total Debt Repaid | 89.44% | 14.56% | 14.56% | 14.56% | -819.54% |
| Issuance of Common Stock | 278.83% | -61.09% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 562.85% | -63.82% | -38.92% | 190.43% | -253.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 214.27% | -89.28% | 27.36% | 91.47% | 23.72% |